44 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares
424B5
8bpkl
24 Mar 22
Prospectus supplement for primary offering
4:15pm
PRE 14A
zv201bo2whua39n4jnah
1 Sep 21
Preliminary proxy
4:46pm
424B5
du3000
20 Aug 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-10.1
e76mze5j
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
8-K
EX-99.1
3qyzu1n71
13 May 21
Processa Pharmaceuticals Announces First Quarter 2021 Results and Provides Corporate Update
5:28pm
424B3
gvd kywtekdhgyprtl
12 Apr 21
Prospectus supplement
1:44pm